Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

We evaluated the prognostic and predictive value of a range of molecular changes in the setting of a randomised trial comparing standard PCV (procarbazine, CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) and vincristine) chemotherapy with the standard temozolomide (TMZ) 5-day (200 mg/m(2)/day) s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Neuropathol Commun
Auteurs principaux: Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229733/
https://ncbi.nlm.nih.gov/pubmed/24952577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-5960-2-68
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires